Dutch biotech firm Vico Therapeutics gathers $31m Series A
Vico Therapeutics, a Dutch biotech company focusing on the development of RNA modulating therapies for rare neurological disorders, has raised $31 million in Series A financing.
Vico Therapeutics, a Dutch biotech company focusing on the development of RNA modulating therapies for rare neurological disorders, has raised $31 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination